Skip to content
HowShorted

Biocept, Inc. short interest in 2018

In 2018, Biocept, Inc.'s disclosed short interest ran from 8.19% of shares outstanding on 12 Jan 2018 to 12.11% on 14 Dec 2018, a change of +3.92 percentage points. The year's high was 19.26% on 31 Oct 2018 and its low 6.24% on 30 Nov 2018, averaging 10.68% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.06 days on 15 May 2018. Full history: Biocept, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Biocept, Inc. in 2018

2018 in figures

Start of year
8.19% (12 Jan 2018)
End of year
12.11% (14 Dec 2018)
Change
+3.92 pp
High
19.26% (31 Oct 2018)
Low
6.24% (30 Nov 2018)
Average
10.68%
Highest days to cover
6.06 (15 May 2018)
SEC filings marked
8

Every report in 2018

Biocept, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20188.19%3.74
31 Jan 20189.67%1.09
15 Feb 201814.78%2.25
28 Feb 201815.15%2.58
15 Mar 201814.37%1.00
29 Mar 20187.54%1.5310-K filed, results (8-K)
13 Apr 20188.43%4.30
30 Apr 20188.35%5.00
15 May 20187.96%6.0610-Q filed, results (8-K)
31 May 20187.78%4.29
15 Jun 20188.96%4.79
29 Jun 20188.18%3.17
15 Aug 201813.08%2.1310-Q filed, results (8-K)
31 Aug 201812.48%1.17
14 Sep 20189.62%2.66
28 Sep 201811.23%1.19
15 Oct 201814.30%1.48
31 Oct 201819.26%1.10
15 Nov 20186.55%4.01results (8-K), 10-Q filed
30 Nov 20186.24%2.27
14 Dec 201812.11%2.03

See also: Biocept, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.